Changzhou Qianhong Biopharma Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001070
CNY
8.10
0.03 (0.37%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,502.53
1,793.87
2,286.45
1,856.59
1,647.65
1,656.35
1,304.71
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,502.53
1,793.87
2,286.45
1,856.59
1,647.65
1,656.35
1,304.71
Raw Material Cost
721.05
1,066.94
1,448.99
1,080.72
911.90
908.91
709.49
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
179.82
200.11
212.24
234.63
0.00
0.00
175.14
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.50
6.17
5.46
1.78
9.10
19.53
19.42
Selling and Distribution Expenses
330.89
481.49
535.65
509.95
844.83
495.06
419.13
Other Expenses
-9.09
-12.01
-13.89
-17.57
4.66
3.31
-14.05
Total Expenditure (Excl Depreciation)
1,142.32
1,634.61
2,063.41
1,651.40
1,812.42
1,456.63
1,182.72
Operating Profit (PBDIT) excl Other Income
360.20000000000005
159.3
223
205.2
-164.8
199.7
122
Other Income
33.56
55.97
151.32
11.13
19.30
123.98
152.01
Operating Profit (PBDIT)
462.90
281.61
442.40
280.51
-74.76
391.53
337.38
Interest
1.50
6.17
5.46
1.78
9.10
19.53
19.42
Exceptional Items
3.49
1.26
0.24
0.94
-0.58
0.38
-0.74
Gross Profit (PBDT)
781.48
726.92
837.46
775.87
735.74
747.44
595.21
Depreciation
69.88
72.97
68.31
64.32
73.64
67.83
63.38
Profit Before Tax
395.01
203.74
368.87
215.35
-158.09
304.55
253.84
Tax
62.66
24.85
40.42
23.04
-21.49
43.59
42.79
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
356.03
181.86
323.41
181.08
-132.02
262.56
221.35
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
356.03
181.86
323.41
181.08
-132.02
262.56
221.35
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-22.85
-3.19
-3.50
5.26
-15.61
-5.65
-10.30
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
333.18
178.67
319.91
186.34
-147.63
256.91
211.04
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,517.44
2,454.93
2,450.35
2,127.25
2,079.99
2,331.86
2,529.79
Earnings per share (EPS)
0.28
0.14
0.25
0.14
-0.11
0.21
0.17
Diluted Earnings per share
0.28
0.14
0.25
0.14
-0.11
0.21
0.17
Operating Profit Margin (Excl OI)
23.92%
8.51%
9.74%
11.04%
-10.18%
12.06%
9.35%
Gross Profit Margin
30.94%
15.43%
19.12%
15.06%
-5.13%
22.48%
24.31%
PAT Margin
23.7%
10.14%
14.14%
9.75%
-8.01%
15.85%
16.97%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is -16.24% vs -21.54% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 86.46% vs -44.14% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 90.29% vs -22.50% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -75.81% vs 12.73% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Changzhou Qianhong Biopharma Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,502.53
0
1,502.53
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,502.53
0
1,502.53
Raw Material Cost
721.05
0
721.05
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
179.82
0
179.82
Power Cost
0
0
0.00
Manufacturing Expenses
1.50
0
1.50
Selling and Distribution Expenses
330.89
0
330.89
Other Expenses
-9.09
0.00
-9.09
Total Expenditure (Excl Depreciation)
1,142.32
0
1,142.32
Operating Profit (PBDIT) excl Other Income
360.22
0.00
360.22
Other Income
33.56
0
33.56
Operating Profit (PBDIT)
462.90
0
462.90
Interest
1.50
0
1.50
Exceptional Items
3.49
0
3.49
Gross Profit (PBDT)
781.48
0
781.48
Depreciation
69.88
0
69.88
Profit Before Tax
395.01
0
395.01
Tax
62.66
0
62.66
Provisions and contingencies
0
0
0.00
Profit After Tax
356.03
0
356.03
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
356.03
0
356.03
Share in Profit of Associates
0
0
0.00
Minority Interest
-22.85
0
-22.85
Other related items
0.00
0.00
0.00
Consolidated Net Profit
333.18
0
333.18
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,517.44
0
2,517.44
Earnings per share (EPS)
0.28
0
0.28
Diluted Earnings per share
0.28
0
0.28
Operating Profit Margin (Excl OI)
23.92%
0%
0.00
23.92%
Gross Profit Margin
30.94%
0%
0.00
30.94%
PAT Margin
23.70%
0%
0.00
23.70%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 150.25 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -16.24% vs -21.54% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 33.32 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 86.46% vs -44.14% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 42.93 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 90.29% vs -22.50% in Dec 2023

Annual - Interest
Interest 0.15 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -75.81% vs 12.73% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.92%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023